Decision-making when data and inferences are not conclusive: risk-benefit and acceptable regret approach.

The absolute truth in research is unobtainable, as no evidence or research hypothesis is ever 100% conclusive. Therefore, all data and inferences can in principle be considered as "inconclusive." Scientific inference and decision-making need to take into account errors, which are unavoidable in the research enterprise. The errors can occur at the level of conclusions that aim to discern the truthfulness of research hypothesis based on the accuracy of research evidence and hypothesis, and decisions, the goal of which is to enable optimal decision-making under present and specific circumstances. To optimize the chance of both correct conclusions and correct decisions, the synthesis of all major statistical approaches to clinical research is needed. The integration of these approaches (frequentist, Bayesian, and decision-analytic) can be accomplished through formal risk:benefit (R:B) analysis. This chapter illustrates the rational choice of a research hypothesis using R:B analysis based on decision-theoretic expected utility theory framework and the concept of "acceptable regret" to calculate the threshold probability of the "truth" above which the benefit of accepting a research hypothesis outweighs its risks.

[1]  Iztok Hozo,et al.  Using the Internet to Calculate Clinical Action Thresholds , 1999, Comput. Biomed. Res..

[2]  S. Goodman Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy , 1999, Annals of Internal Medicine.

[3]  R. Sugden,et al.  Regret Theory: An alternative theory of rational choice under uncertainty Review of Economic Studies , 1982 .

[4]  J. Gabbay,et al.  Evidence based guidelines or collectively constructed “mindlines?” Ethnographic study of knowledge management in primary care , 2004, BMJ : British Medical Journal.

[5]  Nathaniel Rothman,et al.  Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies , 2004 .

[6]  I. Hozo,et al.  When Is Diagnostic Testing Inappropriate or Irrational? Acceptable Regret Approach , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

[7]  M. Millenson,et al.  Cancer- and treatment-related anemia: Clinical Practice Guidelines in Oncology , 2005 .

[8]  B. Löwenberg Post-remission treatment of acute myelogenous leukemia. , 1995, The New England journal of medicine.

[9]  Marc Roubens,et al.  Advances in decision analysis , 1999 .

[10]  D. E. Bell,et al.  Decision making: Descriptive, normative, and prescriptive interactions. , 1990 .

[11]  黄亚明 MedScape , 2009 .

[12]  Detlof von Winterfeldt,et al.  Advances in decision analysis : from foundations to applications , 2007 .

[13]  Les Leventhal,et al.  Directional decisions for two-tailed tests: Power, error rates, and sample size. , 1996 .

[14]  J. Lellouch,et al.  Explanatory and pragmatic attitudes in therapeutical trials. , 1967, Journal of chronic diseases.

[15]  J. Ioannidis Why Most Published Research Findings Are False , 2005, PLoS medicine.

[16]  J. Kassirer,et al.  The threshold approach to clinical decision making. , 1980, The New England journal of medicine.

[17]  I. Hozo,et al.  At what degree of belief in a research hypothesis is a trial in humans justified? , 2002, Journal of evaluation in clinical practice.

[18]  W. Browner,et al.  Are all significant P values created equal? The analogy between diagnostic tests and clinical research. , 1987, JAMA.

[19]  Benjamin Djulbegovic,et al.  Articulating and responding to uncertainties in clinical research. , 2007, The Journal of medicine and philosophy.

[20]  Marcel Zeelenberg,et al.  A Theory of Regret Regulation 1.0 , 2007 .

[21]  A. Willan,et al.  Clinical trials as diagnostic tests. , 1984, Controlled clinical trials.

[22]  D. Kahneman Maps of Bounded Rationality: Psychology for Behavioral Economics , 2003 .

[23]  B Djulbegovic,et al.  Acceptable regret in medical decision making. , 1999, Medical hypotheses.

[24]  Iztok Hozo,et al.  When Should Potentially False Research Findings Be Considered Acceptable? , 2007, PLoS medicine.

[25]  S. Goodman,et al.  Toward Evidence-Based Medical Statistics. 2: The Bayes Factor , 1999, Annals of Internal Medicine.

[26]  B Djulbegovic,et al.  Linking evidence-based medicine therapeutic summary measures to clinical decision analysis. , 2000, MedGenMed : Medscape general medicine.

[27]  Howard Raiffa Decision Analysis: A Personal Account of How It Got Started and Evolved , 2002, Oper. Res..

[28]  D. Cook,et al.  When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment. , 2001, Journal of clinical epidemiology.

[29]  Augustin Ferrant,et al.  Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? , 2007, Blood.

[30]  S J Senn,et al.  Falsificationism and clinical trials. , 1991, Statistics in medicine.

[31]  F. Appelbaum,et al.  Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. , 1998, The New England journal of medicine.

[32]  J. Tukey Conclusions vs Decisions , 1960 .

[33]  B Djulbegovic,et al.  Equation and Nomogram for Calculation of Testing and Treatment Thresholds , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.

[34]  S. Woolf,et al.  Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. , 2002, Blood.

[35]  J. Kagan,et al.  Rational choice in an uncertain world , 1988 .

[36]  A. Ciampi,et al.  Null results in clinical trials: the need for a decision-theory approach. , 1980, British Journal of Cancer.

[37]  J. Kassirer,et al.  Therapeutic decision making: a cost-benefit analysis. , 1975, The New England journal of medicine.

[38]  Marcel Zeelenberg,et al.  A Theory of Regret Regulation 1.1 , 2007 .

[39]  David E. Bell,et al.  Regret in Decision Making under Uncertainty , 1982, Oper. Res..

[40]  F. Mandelli,et al.  Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. , 1995, The New England journal of medicine.

[41]  Ralph F. Miles,et al.  Advances in Decision Analysis: The Emergence of Decision Analysis , 2007 .

[42]  M. Somerfield,et al.  Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.